Delta-like 1-Lysine613 Regulates Notch Signaling

od Zhang, Liguo, Widau, Ryan C., Herring, B. Paul, Gallagher, Patricia J.
Izdano 2011

Protein Phosphatase 2A (PP2A) Holoenzymes Regulate Death-associated Protein Kinase (DAPK) in Ceramide-induced Anoikis

od Widau, Ryan C., Jin, Yijun, Dixon, Shelley A., Wadzinski, Brian E., Gallagher, Patricia J.
Izdano 2010

p19(Arf) Represses Platelet-Derived Growth Factor Receptor β by Transcriptional and Posttranscriptional Mechanisms

od Widau, Ryan C., Zheng, Yanbin, Sung, Caroline Y., Zelivianskaia, Anna, Roach, Lauren E., Bachmeyer, Karen M., Abramova, Tatiana, Desgardin, Aurelie, Rosner, Andrew, Cunningham, John M., Skapek, Stephen X.
Izdano 2012

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)

od Arkenau, Hendrik‐Tobias, Martin‐Liberal, Juan, Calvo, Emiliano, Penel, Nicolas, Krebs, Matthew G., Herbst, Roy S., Walgren, Richard A., Widau, Ryan C., Mi, Gu, Jin, Jin, Ferry, David, Chau, Ian
izdano v Oncologist (2018)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

od Reig, Maria, Galle, Peter R., Kudo, Masatoshi, Finn, Richard, Llovet, Josep M., Metti, Andrea L., Schelman, William R., Liang, Kun, Wang, Chunxiao, Widau, Ryan C., Abada, Paolo, Zhu, Andrew X.
izdano v Liver Int (2020)

STING promotes homeostasis via regulation of cell proliferation and chromosomal stability

od Ranoa, Diana Rose E., Widau, Ryan C., Mallon, Stephen, Parekh, Akash D., Nicolae, Claudia M., Huang, Xiaona, Bolt, Michael J., Arina, Ainhoa, Parry, Renate, Kron, Stephen J., Moldovan, George-Lucian, Khodarev, Nikolai N., Weichselbaum, Ralph R.
izdano v Cancer Res (2018)

RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation

od Widau, Ryan C., Parekh, Akash D., Ranck, Mark C., Golden, Daniel W., Kumar, Kiran A., Sood, Ravi F., Pitroda, Sean P., Liao, Zhengkai, Huang, Xiaona, Darga, Thomas E., Xu, David, Huang, Lei, Andrade, Jorge, Roizman, Bernard, Weichselbaum, Ralph R., Khodarev, Nikolai N.
Izdano 2014

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

od Zhu, Andrew X., Finn, Richard S., Kang, Yoon-Koo, Yen, Chia-Jui, Galle, Peter R., Llovet, Josep M., Assenat, Eric, Brandi, Giovanni, Motomura, Kenta, Ohno, Izumi, Daniele, Bruno, Vogel, Arndt, Yamashita, Tatsuya, Hsu, Chih-Hung, Gerken, Guido, Bilbruck, John, Hsu, Yanzhi, Liang, Kun, Widau, Ryan C., Wang, Chunxiao, Abada, Paolo, Kudo, Masatoshi
izdano v Br J Cancer (2021)

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

od Kudo, Masatoshi, Galle, Peter R., Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S., Llovet, Josep M., Assenat, Eric, Merle, Philippe, Chan, Stephen L., Palmer, Daniel H., Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B., Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C., Zhu, Andrew X.
izdano v JHEP Rep (2020)